Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CeriBell, Inc. - Common Stock (NQ:CBLL)

22.93 +0.14 (+0.61%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 196,060
Open 22.74
Bid (Size) 22.93 (200)
Ask (Size) 22.97 (300)
Prev. Close 22.79
Today's Range 22.27 - 22.96
52wk Range 10.01 - 26.04
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution
Clearance would position the Ceribell System as the first and only point-of-care electroencephalography (EEG) technology to aid in detection and monitoring of Large Vessel Occlusion (LVO) stroke in the... 
From Ceribell
Via GlobeNewswire
News headline image
Ceribell to Participate in the 44th Annual J.P. Morgan Healthcare Conference
From Ceribell
Via GlobeNewswire

Performance

YTD
+7.7%
+7.7%
1 Month
+4.7%
+4.7%
3 Month
+84.0%
+84.0%
6 Month
+45.8%
+45.8%
1 Year
+10.0%
+10.0%

More News

Read More
News headline image
Global AI Infrastructure Shift Ignites Biotech Growth Phase
From USA News Group
Via GlobeNewswire
News headline image
Earnings Scheduled For November 4, 2025 ↗
Via Benzinga
News headline image
Earnings Scheduled For August 5, 2025 ↗
Via Benzinga
News headline image
Earnings Scheduled For May 8, 2025 ↗
Via Benzinga
News headline image
Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution
From Ceribell
Via GlobeNewswire
News headline image
Ceribell Receives FDA 510(k) Clearance for Use of ClarityⓇ Algorithm for Neonates
From Ceribell
Via GlobeNewswire
News headline image
Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference
From Ceribell
Via GlobeNewswire
News headline image
CeriBell (CBLL) Q3 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings Economy World Trade
News headline image
Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
From Ceribell
Via GlobeNewswire
News headline image
Ceribell Reports Third Quarter 2025 Financial Results
From Ceribell
Via GlobeNewswire
News headline image
Ceribell to Report Third Quarter 2025 Financial Results on November 4, 2025
From Ceribell
Via GlobeNewswire
News headline image
Medtech Leader Erica Rogers Joins Ceribell Board of Directors
From Ceribell
Via GlobeNewswire
News headline image
CeriBell (CBLL) Q2 Revenue Jumps 38% ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Ceribell Reports Second Quarter 2025 Financial Results
From Ceribell
Via GlobeNewswire
News headline image
Ceribell to Participate in the Canaccord Genuity 45th Annual Growth Conference
From Ceribell
Via GlobeNewswire
News headline image
Ceribell to Report Second Quarter 2025 Financial Results on August 5, 2025
From Ceribell
Via GlobeNewswire
News headline image
Ceribell Files Complaints Against Natus Medical Incorporated with the U.S. International Trade Commission and Federal Court in Delaware
From Ceribell
Via GlobeNewswire
News headline image
Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference
From Ceribell
Via GlobeNewswire
News headline image
Ceribell Reports First Quarter 2025 Financial Results
From Ceribell
Via GlobeNewswire
News headline image
Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference
From Ceribell
Via GlobeNewswire
News headline image
Ceribell Receives FedRAMP® High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems
From Ceribell
Via GlobeNewswire
News headline image
Ceribell to Report First Quarter 2025 Financial Results on May 8, 2025
From Ceribell
Via GlobeNewswire
News headline image
FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older
From Ceribell
Via GlobeNewswire

Frequently Asked Questions

Is CeriBell, Inc. - Common Stock publicly traded?
Yes, CeriBell, Inc. - Common Stock is publicly traded.
What exchange does CeriBell, Inc. - Common Stock trade on?
CeriBell, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for CeriBell, Inc. - Common Stock?
The ticker symbol for CeriBell, Inc. - Common Stock is CBLL on the Nasdaq Stock Market
What is the current price of CeriBell, Inc. - Common Stock?
The current price of CeriBell, Inc. - Common Stock is 22.93
When was CeriBell, Inc. - Common Stock last traded?
The last trade of CeriBell, Inc. - Common Stock was at 01/14/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.